Sanofi Board to Support Genzyme Bid of Up to $70 a Share ; report

Sanofi-Aventis CEO Chris Viehbacher has support from his board of directors to offer as much as $70 a share for Genzyme Corp., or about $18.7 billion, three people with knowledge of the situation told Bloomberg News.

Be the first to comment

Leave a Reply

Your email address will not be published.